The Office of the U.S. Trade Representative (USTR) published a report on Thursday on its 2024 Review of Notorious Markets for Counterfeiting and Piracy, which focuses on fraudulent online pharmaceutical prescriptions.
“Counterfeiting and piracy is a shared global concern, harming people not just in the United States but also other countries,” said U.S. Trade Representative Ambassador Katherine Tai.